#ESCCongress 2021 Begins Soon!
- Cardio
- 26/08/2021
The ESC Congress 2021, the world’s largest cardiovascular event, begins soon. Get ready for the hottest new science in cardiology from August 27-30. During the scientific meeting, all
READ MOREThe ESC Congress 2021, the world’s largest cardiovascular event, begins soon. Get ready for the hottest new science in cardiology from August 27-30. During the scientific meeting, all
READ MOREA study of more than 18 million pregnancies shows a strong and graded relationship between women’s heart health and pregnancy outcomes. The research is published in the European Journal of
READ MOREEngineers at the University of California San Diego have developed a soft and stretchy ultrasound patch that can be worn on the skin to monitor blood flow through major arteries and veins inside...
READ MOREThe Delta variant of the SARS-CoV-2 virus that causes COVID-19 has contributed to a significant surge in cases around the globe, including India and the U.K. While more and more people continue to...
READ MOREStroke is a complex disease with multiple causes, treatments and consequences. The American Heart Association reports that nearly 80,000 adults in the U.S. will have a new stroke each year. Out of...
READ MOREThe incidence of obesity and diabetes has been increasing at an alarming rate in low- and middle-income countries (LMICs). According to latest figures, of the 463 million people with diabetes worldwi
READ MOREFindings from a new study published in PLOS ONE show that patients taking statins had a 41% lower risk of in-hospital death from COVID-19. Statins are used to reduce blood cholesterol level
READ MOREThe number of people who live past the age of 100 has been increasing for decades. Today, there are nearly half a million people worldwide who are over the age of 100. However, very few people live...
READ MOREAccording to findings from a study published in the British Journal of Medicine, the development of valvular heart disease in patients with chronic heart failure is underestimated and rarely treated.
READ MOREThe RAte control Therapy Evaluation in permanent Atrial Fibrillation (RATE-AF) trial is the first randomised clinical trial of digoxin vs beta-blockers in patients with atrial fibrillation and heart...
READ MORE